颈动脉支架置入前斑块最大扩张对围术期栓塞及血流动力学的影响
这项前瞻性非随机多中心研究分析了2014年1月至2016年8月接受颈动脉支架置入术(CAS)的309例患者,比较支架置入前最大扩张斑块(max-pre-SD,149例)与支架置入后扩张(post-SD,160例)对宏观斑块碎片、血流动力学抑制(HD)及微栓子信号(MES)的影响。结果表明max-pre-SD组宏观碎片、HD和MES均显著减少,但两组围术期主要不良事件无显著差异。
要点
- 支架置入前最大扩张斑块可显著减少宏观斑块碎片和血流动力学抑制。
- max-pre-SD组微栓子信号计数显著低于post-SD组。
- 两组围术期主要不良事件(小卒中、大卒中)无显著差异。
核心结论
- 支架置入前最大扩张斑块似乎是CAS手术安全可行的技术改良,可显著减少宏观碎片、HD和MES。
- 需要更大规模的随机队列研究来确立该技术改良的优越性。
研究设计与样本
- 前瞻性非随机多中心研究,纳入2014年1月至2016年8月因颈动脉狭窄接受CAS的患者309例。
- 149例接受支架置入前最大扩张斑块(max-pre-SD),160例接受支架置入后扩张(post-SD)。
- 所有患者使用近端封堵脑栓塞保护装置,技术成功率为100%。
主要发现
- max-pre-SD组与post-SD组在宏观碎片和HD方面差异显著,有利于max-pre-SD(P < .001)。
- max-pre-SD组平均MES计数显著低于post-SD组(8.1% vs 68.1%;P < .001)。
- post-SD组术后即刻MES风险显著高于max-pre-SD组(41.9% vs 1.3%;P < .001)。
- post-SD组宏观碎片收集风险增加12倍(OR 12.36;95%CI 5.68-26.87;P < .001),HD风险增加18倍(OR 17.80;95%CI 5.27-60.17;P < .001)。
- 异质性、主要为低回声的斑块类型显著增加宏观碎片风险(OR 78.45;95%CI 8.70-707.09;P < .001),但对HD为保护因素(OR 0.02;95%CI 0.006-0.11;P < .001)。
临床怎么用
- 对于接受CAS的颈动脉狭窄患者,可考虑采用支架置入前最大扩张斑块的技术改良以减少宏观碎片、HD和MES。
- 该技术改良的长期获益及优越性仍需更大规模随机研究验证。
局限性
- 本研究为非随机设计,可能存在选择偏倚。
- 样本量有限,围术期主要不良事件数量少,需更大规模随机队列进一步验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Plaque stability is of utmost importance for stroke prevention in the perioperative period (within 24 hours) following carotid artery stenting (CAS). Although carotid plaque is entrapped between stent struts after stent deployment, postdilation can cause a scissoring effect on the plaque, increasing the risk of postprocedural embolic events due to plaque prolapse. Maximum carotid plaque dilation before stent deployment may reduce this risk. This study analyzed the effect of maximum dilation of the carotid plaque before stent deployment (max-pre-SD) or after stent deployment (post-SD) on macroscopic plaque debris, hemodynamic depression (HD), and immediate major adverse events. METHODS: This prospective nonrandomized multicenter study analyzed patients treated for carotid artery stenosis with CAS from January 2014 to August 2016. Clinical and morphologic characteristics and operative details were analyzed with logistic regression analysis for macroscopic debris and HD. The number of microembolic signals (MESs) was assessed by transcranial Doppler and analyzed. RESULTS: A total of 309 patients were enrolled and treated with standard CAS performed using a proximal occlusion cerebral embolic protection device; 149 received max-pre-SD and 160 were treated with post-SD. Technical success was achieved in 100% of cases. Macroscopic debris and HD were significantly different between the two groups in favor of max-pre-SD (P < .001). A significant difference in intraprocedural MESs between the groups was detected. Compared with post-SD, max-pre-SD significantly reduced mean MES counts (8.1% vs 68.1%; P < .001). Patients treated with post-SD had a significantly increased risk of MESs in the immediate postoperative period compared with patients treated with max-pre-SD (41.9% vs 1.3%; P < .001).This result was mainly due to the small number of events encountered. Patients treated with post-SD had a 12-fold increased risk of macroscopic debris collection (odds ratio [OR], 12.36; 95% confidence interval [CI], 5.68-26.87; P < .001) and an 18 times increase in HD risk (OR, 17.80; 95% CI, 5.27-60.17; P < .001) compared with patients treated with max-pre-SD. The heterogeneous, mainly echolucent plaque type significantly highly increased the risk of macroscopic debris (OR, 78.45; 95% CI, 8.70-707.09; P < .001) while acting as a protective factor against HD (OR, 0.02; 95% CI, 0.006-0.11; P < .001) along with echogenic or echolucent complex plaques with irregular surface plaque types (OR, 0.10; 95% CI, 0.031-0.336; P < .001). No significant differences between groups (max-pre-SD group and post-SD) were detected in immediate major adverse events (minor stroke, 2.0% and 2.5% [P = .461]; major stroke, 0% and 0.6% [P = .334], respectively). CONCLUSIONS: Max-pre-SD seems to be a safe and feasible technical modification to the CAS procedure. Macroscopic debris, HD, and MESs are significantly reduced compared with CAS with post-SD. Further research with larger, randomized cohorts of patients is required to establish the superiority of this technical modification.
引用
- Lauricella A, Berchiolli R, Moratto R, et al. Impact of plaque dilation before carotid artery stent deployment. J Vasc Surg. 2019. PMID: 31471234. doi:10.1016/j.jvs.2019.05.048
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。